Outcomes of Critically Ill Children With Acute Lymphoblastic Leukemia and Cytokine Release Syndrome Due to Chimeric Antigen Receptor T Cell Therapy: US, Multicenter PICU, Cohort Database Study.

MLA

Logan, Grace E., et al. “Outcomes of Critically Ill Children With Acute Lymphoblastic Leukemia and Cytokine Release Syndrome Due to Chimeric Antigen Receptor T Cell Therapy: US, Multicenter PICU, Cohort Database Study.” Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, vol. 23, no. 12, Dec. 2022, pp. e595–600. EBSCOhost, https://doi.org/10.1097/PCC.0000000000003079.

APA

Logan, G. E., Miller, K., Kohler, M. E., Loi, M., & Maddux, A. B. (2022). Outcomes of Critically Ill Children With Acute Lymphoblastic Leukemia and Cytokine Release Syndrome Due to Chimeric Antigen Receptor T Cell Therapy: US, Multicenter PICU, Cohort Database Study. Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 23(12), e595–e600. https://doi.org/10.1097/PCC.0000000000003079

Chicago

Logan, Grace E, Kristen Miller, M Eric Kohler, Michele Loi, and Aline B Maddux. 2022. “Outcomes of Critically Ill Children With Acute Lymphoblastic Leukemia and Cytokine Release Syndrome Due to Chimeric Antigen Receptor T Cell Therapy: US, Multicenter PICU, Cohort Database Study.” Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 23 (12): e595–600. doi:10.1097/PCC.0000000000003079.